A Clinical Trial for CTD-ILD Treatment
NCT01424033 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 5
Last updated 2017-04-06
Summary
The first objective of this protocol is to assess the tolerability and safety of N-acetylcysteine (NAC) in patients with connective tissue disease related interstitial lung disease (CTD-ILD).
Conditions
- Interstitial Lung Disease
- Connective Tissue Disease
Interventions
- DRUG
-
N-Acetylcysteine
600mg by mouth, three times daily for 12 months
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-12-31
- Primary Completion
- 2013-02-28
Countries
- United States
Study Locations
More Related Trials
-
The Anti-oxidant Effects of N-Acetylcysteine in Chronic Obstructive Pulmonary Disease (COPD)
NCT03956888 ·Status: COMPLETED ·Phase: PHASE3
-
Risk Factors and Prognostic Parameters of Interstitial Lung Disease in Children
NCT06125288 ·Status: NOT_YET_RECRUITING
-
Interstitial Lung Disease Associated
NCT06007040 ·Status: COMPLETED
-
Interstitial Lung Diseases Cohort Study in China
NCT04370158 ·Status: UNKNOWN
-
Anti-inflammatory Effects of Caffeine in Chronic Obstructive Pulmonary Disease (COPD) Subjects
NCT00826566 ·Status: WITHDRAWN ·Phase: NA
-
Autologous Stem Cell Treatment for Chronic Lung Disease Study
NCT03044431 ·Status: COMPLETED
-
Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
NCT00281216 ·Status: COMPLETED
-
Development of Airway Absorption Sampling Methods
NCT04494334 ·Status: WITHDRAWN
-
T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT00281229 ·Status: COMPLETED
-
Biological Determinants of Sputum Rheology in Chronic Airway Diseases
NCT04081740 ·Status: COMPLETED
-
Cross-sectional Characterization of Idiopathic Bronchiectasis
NCT01264055 ·Status: COMPLETED
-
Effects of Electronic Cigarettes on Lung Biology
NCT02188511 ·Status: TERMINATED ·Phase: NA
-
Exploratory Study of Potential Pulmonary Aspiration Markers From Bronchoalveolar Lavage Fluid
NCT00915941 ·Status: COMPLETED
-
PRospective Evaluation of Interstitial Lung DIsease Progression With Quantitative CT
NCT05609201 ·Status: ENROLLING_BY_INVITATION
-
IL-17 Neutrophils in CF Lung Inflammation
NCT02025829 ·Status: COMPLETED
-
Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) Patients
NCT05503030 ·Status: ACTIVE_NOT_RECRUITING
-
Predictive Ability of the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) for Acute Exacerbations (PACE) in Patients With COPD
NCT01254032 ·Status: COMPLETED
-
Development of a Noninvasive Method of Evaluation of Pulmonary Inflammation in the Condensates of Exhaled Air
NCT00356629 ·Status: TERMINATED
-
Genetic Causes and Clinical Features of Childhood Interstitial Lung Diseases in China
NCT03869515 ·Status: COMPLETED
-
Neutrophil Imaging in Healthy Subjects Following Lipopolysaccharide or Saline Challenge and in Subjects With Chronic Obstructive Pulmonary Disease
NCT02551614 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)
NCT02827734 ·Status: UNKNOWN
-
Doxycycline and Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD)
NCT00857038 ·Status: UNKNOWN ·Phase: PHASE4
-
Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases
NCT04119115 ·Status: TERMINATED
-
Interstitial Lung Disease Exacerbations Study
NCT06685874 ·Status: ACTIVE_NOT_RECRUITING
-
Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease
NCT06012500 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2